Skip to main navigation Skip to search Skip to main content

Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Translated title of the contribution: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
  • C. Bossard
  • , K. Belhadj
  • , F. Reyes
  • , N. Martin-Garcia
  • , F. Berger
  • , J.A. Kummer
  • , J. Brière
  • , A-C. Baglin
  • , S. Cheze
  • , J. Bosq
  • , V. Ribrag
  • , C. Gisselbrecht
  • , N. Mounier
  • , P. Gaulard

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionExpression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Original languageUndefined/Unknown
Pages (from-to)2183-2189
Number of pages7
JournalBlood
Volume109
Issue number5
Publication statusPublished - 2007

Cite this